Treating muscular dystrophy with stem cells

K.E. Davies; Miranda Grounds

doi:10.1016/j.cell.2006.12.010

Treating muscular dystrophy with stem cells

K.E. Davies, Miranda Grounds

Research output: Contribution to journal › Review article

31 Citations (Scopus)

Abstract

There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.

Original language	English
Pages (from-to)	1304-1306
Journal	Cell
Volume	127
Issue number	7
DOIs	https://doi.org/10.1016/j.cell.2006.12.010
Publication status	Published - 2006

Access to Document

10.1016/j.cell.2006.12.010

Fingerprint Dive into the research topics of 'Treating muscular dystrophy with stem cells'. Together they form a unique fingerprint.

Cite this

@article{b86949954aa844f095bdc96912f15940,

title = "Treating muscular dystrophy with stem cells",

abstract = "There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.",

author = "K.E. Davies and Miranda Grounds",

year = "2006",

doi = "10.1016/j.cell.2006.12.010",

language = "English",

volume = "127",

pages = "1304--1306",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "7",

}

TY - JOUR

T1 - Treating muscular dystrophy with stem cells

AU - Davies, K.E.

AU - Grounds, Miranda

PY - 2006

Y1 - 2006

N2 - There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.

AB - There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.

U2 - 10.1016/j.cell.2006.12.010

DO - 10.1016/j.cell.2006.12.010

M3 - Review article

C2 - 17190595

VL - 127

SP - 1304

EP - 1306

JO - Cell

JF - Cell

SN - 0092-8674

IS - 7

ER -